CIK 0001593899
- Non-accelerated filer
- Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 460574869
- Phone
- +1 857-284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-31 | Foster Wayne EVP, Chief Accounting Officer | Exercise or conversion | +41,333 | 91,461 | ||
| 2026-01-31 | Foster Wayne EVP, Chief Accounting Officer | Shares withheld for taxes | −12,132 | $4.24 | $51K | 79,329 |
| 2026-01-31 | Foster Wayne EVP, Chief Accounting Officer | Exercise or conversion · Restricted Stock Units | −33,333 | 0 | ||
| 2026-01-31 | Foster Wayne EVP, Chief Accounting Officer | Exercise or conversion · Restricted Stock Units | −8,000 | 0 | ||
| 2026-01-31 | Foster Wayne EVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +108,000 | 108,000 | ||
| 2025-01-31 | Foster Wayne EVP, Chief Accounting Officer | Exercise or conversion | +33,333 | 54,190 | ||
| 2025-01-31 | Foster Wayne EVP, Chief Accounting Officer | Grant or award | +8,000 | 62,190 | ||
| 2025-01-31 | Foster Wayne EVP, Chief Accounting Officer | Shares withheld for taxes | −12,062 | $3.06 | $37K | 50,128 |
| 2025-01-31 | Foster Wayne EVP, Chief Accounting Officer | Exercise or conversion · Restricted Stock Units | −33,333 | 33,333 | ||
| 2025-01-31 | Foster Wayne EVP, Chief Accounting Officer | Grant or award · Restricted Stock Units | +8,000 | 8,000 | ||
| 2025-01-31 | Foster Wayne EVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +120,100 | 120,100 | ||
| 2024-02-01 | Foster Wayne EVP, Chief Accounting Officer | Sale | −12,477 | $3.84 | $48K | 20,857 |
| 2024-01-31 | Foster Wayne EVP, Chief Accounting Officer | Exercise or conversion | +33,334 | 33,334 | ||
| 2024-01-31 | Foster Wayne EVP, Chief Accounting Officer | Exercise or conversion · Restricted Stock Units | −33,334 | 66,666 | ||
| 2024-01-31 | Foster Wayne EVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +120,100 | 120,100 | ||
| 2023-01-31 | Foster Wayne EVP, Chief Accounting Officer | Grant or award · Restricted Stock Units | +100,000 | 100,000 | ||
| 2023-01-31 | Foster Wayne EVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2022-01-31 | Foster Wayne EVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2021-01-29 | Foster Wayne | Grant or award · Stock Option (Right to Buy) | +71,750 | 71,750 | ||
| 2020-10-29 | Foster Wayne | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 1 of 1 · 20 trades